Initial Observations on the COVID-19 Pandemic

Only 10% of pharma’s patient programmes measure the patient experience. To address this gap, a leading global pharmaceutical company engaged Vynamic as a strategic partner to establish a Patient Innovation Hub that will help change the way the industry develops patient-focused solutions in the future.

The leadership of a large global pharmaceutical company placed a priority focus on Diversity, Equity, & Inclusion (DEI) and engaged Vynamic to help define and mobilize a roadmap of initiatives with the intention of embedding more holistic DEI thinking within the organization. Read how Vynamic helped instill accountability among the company leadership to ensure DEI would have a long-lasting impact on employees.